EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning

Isabella Gruber, Matthias Edinger, Hendrik Poeck, Elisabeth Meedt, Daniela Weber, Ernst Holler, Wolfgang Herr, Oliver Koelbl, Daniel Wolff

Supportive Care in Cancer · 2026-12 · 34 (12)

DOI: 10.1007/s00520-026-11471-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 18.11.2026. Verfasst von Isabella Gruber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany. i.gruber@ukr.de. Hauptthemen laut MEDLINE: Whole-Body Irradiation, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hematopoietic Stem Cell Transplantation, Stomatitis. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Regensburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We evaluated the association between total body irradiation (TBI) dose and severe oral mucositis (OM) in adults with acute lymphoblastic leukemia (ALL) undergoing myeloablative allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Methods

We analyzed 101 adults receiving 8 or 12 Gy TBI. Severe OM was defined as WHO grades 3–4. TBI allocation was non-randomized, with 8 Gy more frequently used in older patients and those with a Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) > 3. Multivariable logistic regression assessed factors associated with severe OM, with the Karnofsky Performance Status (KPS) included in the primary model; sensitivity analyses evaluated alternative models.

Results

Severe OM occurred in 48 patients (47.5%) and was more frequent after 12 than 8 Gy (62.0% vs. 33.3%, P = 0.005). In the primary model, 12 Gy TBI was associated with higher odds of severe OM (OR 2.78, 95% CI 1.17–6.78; P = 0.022). The association between 12 Gy TBI and severe OM remained significant when HCT-CI replaced KPS and after calendar-year adjustment. After age adjustment, the estimate was similar, but the confidence interval widened and included the null (OR 2.63, 95% CI 0.90–8.06; P = 0.081). Severe OM was associated with a 4-day longer median hospital stay (41 vs. 37 days, P = 0.001) and a 5-day longer median duration of systemic therapeutic antibiotic treatment (20 vs. 15 days, P = 0.002). Neither measure differed significantly by TBI dose.

Conclusion

Higher TBI dose was associated with severe OM; severe OM was associated with longer hospital stays and systemic therapeutic antibiotic treatment. Findings should be interpreted cautiously given non-randomized TBI allocation. Clinical trial registration This study is a retrospective analysis and was not registered as a clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole-Body IrradiationPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoietic Stem Cell TransplantationStomatitisTransplantation ConditioningHumansAdultFemaleMaleMiddle AgedYoung AdultRetrospective StudiesSeverity of Illness IndexLogistic ModelsAgedKarnofsky Performance StatusAdolescentLength of StayTransplantation, Homologous

Stichwörter der Autor:innen

Antibiotic therapyHematopoietic stem cell transplantationHospital stayOral mucositisTotal body irradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany. i.gruber@ukr.de.
  • Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany.

Förderung

  • Universitätsklinikum Regensburg

Zitieren

APA

Gruber, I., Edinger, M., Poeck, H., Meedt, E., Weber, D., Holler, E., Herr, W., Koelbl, O., & Wolff, D. (2026). Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning. Supportive Care in Cancer, 34(12). https://doi.org/10.1007/s00520-026-11471-7

Vancouver

Gruber I, Edinger M, Poeck H, Meedt E, Weber D, Holler E, et al. Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning. Supportive Care in Cancer. 2026;34(12). doi:10.1007/s00520-026-11471-7

BibTeX
@article{Gruber2026,
  author = {Gruber, Isabella and Edinger, Matthias and Poeck, Hendrik and Meedt, Elisabeth and Weber, Daniela and Holler, Ernst and Herr, Wolfgang and Koelbl, Oliver and Wolff, Daniel},
  title = {Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {12},
  doi = {10.1007/s00520-026-11471-7}
}
Kostenlos starten →